Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

APO-CIMETIDINE ORAL SOLUTION 300 MG / 5 ML

CIMETIDINE (CIMETIDINE HYDROCHLORIDE) : 300 MG / 5 ML · DIN 02243085 · APOTEX INC

Health Canada status: CANCELLED POST MARKET

What is APO-CIMETIDINE ORAL SOLUTION?

APO-CIMETIDINE ORAL SOLUTION 300 MG / 5 ML contains CIMETIDINE (CIMETIDINE HYDROCHLORIDE) : 300 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 02243085, held by APOTEX INC, supplied as LIQUID for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 17-Apr-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02243085
Brand nameAPO-CIMETIDINE ORAL SOLUTION
Generic / active ingredientCIMETIDINE (CIMETIDINE HYDROCHLORIDE) : 300 MG / 5 ML
ManufacturerAPOTEX INC
Strength300 MG / 5 ML
Dosage formLIQUID
Route of administrationORAL
SchedulePrescription
ATC codeA02BA01 CIMETIDINE
AHFS class56:28.12
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date17-Apr-2025
Original market date2001-01-05 00:00:00

Is CIMETIDINE in shortage in Canada?

A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by AA PHARMA INC, last seen 16 Jun 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for APO-CIMETIDINE ORAL SOLUTION

What can be used instead?

Other Canadian products sharing ATC code A02BA01 CIMETIDINE. 2 of 50 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
CIMETIDINE200 MGTABLETAA PHARMA INCMARKETEDDIN 00584215
CIMETIDINE300 MGTABLETAA PHARMA INCMARKETEDDIN 00487872
CIMETIDINE400 MGTABLETAA PHARMA INCDORMANTDIN 00600059
CIMETIDINE600 MGTABLETAA PHARMA INCDORMANTDIN 00600067
CIMETIDINE800 MGTABLETAA PHARMA INCDORMANTDIN 00749494
CIMETIDINE 200 TAB 200MG200 MGTABLETPRO DOC LIMITEECANCELLED POST MARKETDIN 00596469
CIMETIDINE TAB 300MG300 MGTABLETPRO DOC LIMITEECANCELLED POST MARKETDIN 00596477
CIMETIDINE TAB 400MG400 MGTABLETPRO DOC LIMITEECANCELLED POST MARKETDIN 00618691
CIMETIDINE TAB 600MG600 MGTABLETPRO DOC LIMITEECANCELLED POST MARKETDIN 00618705
DOM-CIMETIDINE200 MGTABLETDOMINION PHARMACALCANCELLED PRE MARKETDIN 02231285

Who else supplies CIMETIDINE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. CIMETIDINE appears in 47 registered pack listings across 5 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02243085. Last reviewed 2026-09-09. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.